Back to search
FDAFDA · Food and drugs·Recall number D-0330-2023

Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500 090, INDIA; NDC 55111-525-01.

Published March 1, 2023 · Recall initiated: February 8, 2023

Summary

FDA records drug Class II recall D-0330-2023, published March 1, 2023 and initiated February 8, 2023. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 4,320 bottles; Lot: Lot # C2106445; Exp. 03/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email if TACROLIMUS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TACROLIMUS
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide in the USA
UPC
0355111527015
Lot
Lot # C2106445; Exp. 03/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500 090, INDIA; NDC 55111-525-01. recalled?

Yes. FDA published recall D-0330-2023 on March 1, 2023. Reported hazard: Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0355111527015.